Changes in Shape and Osmotic Resistance of Human Erythrocytes resulted from Changes in the Lysolecithin Content of the Membranes
スポンサーリンク
概要
- 論文の詳細を見る
Incubation of human erythrocytes in lysolecithin-containing medium, prepared by an addition of purified lysolecithin to blood plasma or to phosphate-buffered saline, induced the increases in lysolecithin content of the erythrocyte membranes as well as morphological changes of the cells from normal biconcave disc to crenated or spherical forms. The erythrocytes with slight excess of lysolecithin incorporated, which take shapes of crenated disc or crenated sphere, rather have increased osmotic resistance, whereas those with much more lysolecithin, taking almost spherical form, show reduced osmotic resistance. After washing these erythrocytes with heated normal plasma to remove excess lysolecithin from the membrane, the increased osmotic resistance observed in the former erythrocyte preparation was restored to the normal level, whereas the decreased resistance in the latter cell preparation was never reversed, in spite of the restoration to the normal morphological shape.
- 社団法人日本薬学会の論文
- 1974-01-25
著者
-
佐藤 隆司
京都薬科大学
-
佐藤 隆司
京都薬大
-
藤井 達三
京都薬科大学
-
藤井 達三
Faculty Of Pharmacy Meijo University
-
佐藤 隆司
Faculty of Pharmacy, Meijo University
関連論文
- マクロファージにおけるマトリックスメタロプロテアーゼ-9産生への細胞質ホスホリパーゼA_2α関与
- 肝での脂肪蓄積への group IVA phospholipase A_2 の関与
- シメチジンの用量と薬物相互作用発現の関係 : 文献調査ならびにテオフィリン体内動態の変動
- 各種ヨード造影剤のヒト血小板凝集抑制作用の比較
- 薬学に託す21世紀
- Mechanism of Antioxidant Action of Pueraria Glycoside (PG)-1 (an Isoflavonoid) and Mangiferin (a Xanthonoid)
- Antioxidant Activity of Indapamide and Its Metabolite
- 薬剤師会との連携で(活気ある支部活動)
- Relationship between Drug-and Phospholipase-Induced Shape Changes of Human Erythrocytes
- プロトポルフィリンのヒト赤血球膜に対する影響
- 諸種薬物のヒト赤血球内Kイオン流出促進効果と膜変形誘起効果との比較
- Shape-transforming Action of Myrmicacin (3-Hydroxydecanoic Acid) and Some Related Compounds on the Membrane of Intact Human Erythrocytes
- 「年会一般講演の座長のあり方」のパネルを読んで : その2
- ヒト赤血球膜に対するフェノチアジン系向精神薬の作用
- 両親媒性薬物によるヒト赤血球の変形と浸透圧抵抗性変化との関連
- Binding of Calcium and Magnesium Ions to Human Erythrocyte Membranes
- Changes in Shape and Osmotic Resistance of Human Erythrocytes resulted from Changes in the Lysolecithin Content of the Membranes
- Calcium and Magnesium Contents of Mammalian Erythrocyte Membranes
- Abnormal Distribution of Phospholipids in Aorta of the Rabbits with Experimental Atherosclerosis
- Phospholipid Distribution in Erythrocyte and Plasma of the Man, Cow, Pig and Rabbit
- 低酸素が誘導する血管平滑筋細胞遊走因子としてのトロンボスポンジン-1の作用機構(誌上シンポジウム)
- 細胞質ホスホリパーゼA_2α欠損マウスの脂肪組織および肝における脂質の蓄積低下
- 高グルコースメジウム中での培養ラットメサンギウム細胞におけるホスホリパーゼA_2活性
- 各種漢方方剤のウサギ血小板ホスホリパーゼA_2阻害効果及び高コレステロール血症ウサギの血小板凝集能亢進に対する当帰芍薬散の抑制効果
- 血液細胞の細胞膜におけるリン脂質の動態と機能.両親媒性薬物の作用機構に関連して
- まるごとの細胞で膜を研究する者の繰り言(生体膜研究の展望)
- Disturbing Effect of Cationic Amphiphilic Drugs on Phospholipid Asymmetry of the Membrane Lipid Bilayer of Human Erythrocytes
- ヒト赤血球膜に対するペニシリンの作用
- Some Common Characteristics of the Acetylcholinesterase of Human, Bovine and Porcine Erythrocytes
- Effects of Calcium Ions on the Adenosine-Triphosphatase Activities of Erythrocyte Membrane
- Dissociative Behavior of High-Density Lipoprotein of Egg Yolk
- Aggregation of High-density Lipoproteins from Egg Yolk
- 日本薬学会教育賞受賞, 藤井達三氏の業績
- 赤血球と血小板の細胞膜における膜リン脂質の多彩な役割 (血液細胞の細胞膜の研究における最近の進歩)
- 赤血球膜の構造と機能
- 血小板の膜流動性変化とホスホリパ-ゼA2活性
- Variability in the Lysolecithin Content of Human Erythrocyte Membranes
- Synthesis of Spiro [4-hydroxycyclohexane-1,4'-2', 3'-dihydro-6'-methoxy-2'-methyl-1'H-isoquinoline]
- 血小板の膜流動性変化とホスホリパーゼA2活性
- 赤血球と血小板の細胞膜における膜リン脂質の多彩な役割 (血液細胞の細胞膜の研究における最近の進歩)
- Characteristics of Human Erythrocytes with Artific Ally-Increased ATP and/or 2, 3-Diphosphoglycerate Contents
- Hyperlipidemia and Erythrocyte Shape Change
- タイトル無し
- Furlher Sludies on Enzymic Determination of Plasma Sphingomyelin:The Comparison with TLC Method
- Possible Adsorption of Aldolase and Glyceraldehyde-3-Phosphate Dehydrogenase into the Erythrocyte Ghosts Prepared Under a Hypotonic Condition
- Increase in the Activity of Rhizopus C-Lipase on Human Plasma Lipoproteins by Treatment with Phospholipid